Michael J Dennis

10PUBLICATIONS
114CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 09, 2025
Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.

Glenn J Hanna, Nicole Scarfo, Kee-Young Shin

|May 15, 2025
Real-World Analysis of Disparities in Biomarker Testing and Use of Recommended Targeted Therapies in Metastatic Non-Small Cell Lung Cancer in the United States.

Michael J Dennis, Devin Abrahami, Maria Cecilia Vieira

|Dec 03, 2024
Duvelisib with Docetaxel for Patients with Anti-PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma.

Glenn J Hanna, L B Oakley, R Shi

|Oct 22, 2024
Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma.

Michael J Dennis, Dean C Pavlick, Alec Kacew

|Jun 02, 2024
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell Carcinoma.

Glenn J Hanna, Michael J Dennis, Nicole Scarfo

|Feb 15, 2024
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer.

Sandip P Patel, Elizabeth Guadarrama, Young Kwang Chae

Pageof 2

Frequent Collaborators

4 joint publications

Sandip Pravin Patel

3 joint publications

Glenn J Hanna

3 joint publications

Nicole Scarfo

3 joint publications

Kartik Sehgal